|
2023
|
Invention
|
Compositions comprising at least an insulin and an amylin receptor agonist for treating diabetes,... |
|
|
Invention
|
Hydrogels for cell therapy. The invention concerns cross-linked dextran polymer Dx bearing anioni... |
|
|
Invention
|
Hydrogels for drug delivery. ii is a linear or branched polyether or POx - i is the valence of L ... |
|
|
Invention
|
Hydrogels for cell therapy. [0001] The invention concerns a hydrogel comprising the crosslinked d... |
|
|
Invention
|
Compositions comprising a peptide or a protein and an acylated amino acid. The invention relates ... |
|
|
P/S
|
Chemical products in the form of polymers for use in the manufacture of pharmaceutical preparatio... |
|
|
P/S
|
Chemical products in the form of polymers for use in
science, in the pharmaceutical, dietetic an... |
|
2022
|
Invention
|
Implantable device comprising a hydrogel. [000509] The invention concerns an implantable device c... |
|
|
P/S
|
Chemical products in the form of unprocessed polymers, namely, hydrogel, for use in science, in t... |
|
|
P/S
|
Chemical products in the form of polymers, namely hydrogel,
for use in science, in the pharmaceu... |
|
|
P/S
|
Chemical products in the form of polymers or small molecules
for use in science, in the pharmace... |
|
|
P/S
|
Chemical products in the form of unprocessed polymers or small molecules being industrial chemica... |
|
|
Invention
|
Solid compositions comprising a peptide or a protein and an acylated amino acid. The invention re... |
|
|
Invention
|
Compositions comprising short-acting hormones for treating or preventing obesity and pumps compri... |
|
|
Invention
|
Hydrogels for cell therapy. Crosslinked dextran polymer, bearing carboxylate groups, wherein at l... |
|
|
Invention
|
Hydrogels for cell therapy.
A crosslinked dextran polymer, bearing carboxylate groups, wherein a... |
|
2021
|
P/S
|
Chemical products, namely, polymers for the manufacture of industrial, consumer, and household pr... |
|
|
Invention
|
Compositions in the form of an injectable aqueous solution comprising amylin, an amylin agonist r... |
|
|
Invention
|
Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-pol... |
|
|
Invention
|
Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor ... |
|
|
Invention
|
Pharmaceutical composition in the form of an injectable aqueous solution including at least a rap... |
|
|
Invention
|
Ph 7 injectable solution comprising at least one basal insulin of which the pi is from 5.8 to 8.5... |
|
|
Invention
|
Compositions comprising at least an amylin receptor agonist and a glp-1 receptor agonist.
An inv... |
|
|
Invention
|
Compositions comprising at least an amylin receptor agonist and a glp-1 receptor agonist. The inv... |
|
2020
|
Invention
|
Rapid-acting insulin formulation comprising a substituted anionic compound. A composition in aque... |
|
|
Invention
|
Injectable ph 7 solution comprising at least one basal insulin having a pi from 5.8 to 8.5 and a ... |
|
|
Invention
|
Injectable solution at ph 7 containing at least one basal insulin, the pi of which is between 5.... |
|
|
Invention
|
Compositions in the form of an injectable aqueous solution including at least human insulin a21g ... |
|
2019
|
Invention
|
Method for preparing a stable composition in the form of an injectable aqueous solution. The inve... |
|
|
Invention
|
Injectable solution at ph 7 comprising at least one basal insulin the pi of which is from 5.8 to ... |
|
|
Invention
|
Compositions in the form of an injectable aqueous solution comprising amylin an amylin receptor a... |
|
|
Invention
|
Injectable solution at ph 7, comprising at least one basal insulin with a pi between 5.8 and 8.5,... |
|
|
Invention
|
Injectable solution having ph 7 and comprising human glucagon, at least one ionic species, and an... |
|
|
Invention
|
Thermostable formulation of a21g human insulin.
A composition in the form of an injectable aqueo... |
|
|
Invention
|
Thermostable formulation of a21g human insulin. The invention relates to a composition in the for... |
|
|
Invention
|
Injectable solution at ph 7, comprising at least one basal insulin whose pi is between 5.8 and 8.... |
|
|
Invention
|
Device for injecting an insulin solution. The invention relates to a device (1) for injecting or ... |
|
|
Invention
|
Injectable composition with a ph of 7 comprising a co-polyaminoacid bearing carboxylate charges a... |
|
2018
|
Invention
|
Injectable solution at ph 7 comprising at least one basal insulin which pi is from 5.8 to 8.5 a... |
|
|
Invention
|
Injectable solution at ph 7 comprising at least one basal insulin wherein the pi is comprised fro... |
|
|
Invention
|
Ph 7 injectable solution comprising at least one basic insulin with a pi comprised from 5.8 to 8.... |
|
|
Invention
|
Injectable solution at ph 7 comprising at least a basal insulin which pi is comprised between 5.8... |
|
|
Invention
|
Injectable solution at ph 7 comprising at least one basal insulin for which the pi is from 5.8 to... |
|
2016
|
P/S
|
Chemical products for use in science, namely, polymers for the manufacture of pharmaceutical prep... |
|
|
P/S
|
Chemical products for use in science, in the medical and
pharmaceutical industries. Chemical pro... |
|
2008
|
P/S
|
Chemical products (polymers for scientific applications, the
pharmaceutical, dietetic and medica... |
|
|
P/S
|
Chemicals (polymers used in science and the pharmaceutical, dietetic and medical industries). Che... |
|
|
P/S
|
Chemicals (polymers) used in science and the pharmaceutical, dietetic and medical industries. Che... |
|
|
P/S
|
Chemical products (polymers) for scientific applications,
the pharmaceutical, dietetic and medic... |
|
2006
|
P/S
|
Chemical products intended to be integrated in medicines in
such a way as to promote their diffu... |
